Global Point-Of-Care Diagnostics Devices And Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Infectious Disease Testing Kits, Cardio Metabolic Monitoring Kits, , Cholesterol Testing Kits, Pregnancy, and Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits and Others.By Prescription Mode;
Prescription-based Testing Devices, and Over-The-Counter (OTC) Testing Devices.By End User;
Professional Diagnostic Centers, Hospitals/Critical Care Centers, Outpatient Healthcare Setting, Ambulatory Care Settings, Research Laboratories, and Home.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Point-Of-Care Diagnostics Devices And Equipment Market (USD Million), 2021 - 2031
In the year 2024, the Global Point-Of-Care Diagnostics Devices And Equipment Market was valued at USD 35,702.21 million. The size of this market is expected to increase to USD 84,997.33 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 13.2%.
The Global Point-of-Care (POC) Diagnostics Devices and Equipment Market encompasses a wide range of medical devices and equipment designed for rapid testing and diagnosis of various health conditions at the point of care, outside of traditional laboratory settings. These devices play a crucial role in facilitating timely and accurate diagnosis, enabling healthcare providers to make informed treatment decisions quickly and efficiently. The market for POC diagnostics devices and equipment has witnessed significant growth in recent years, driven by factors such as increasing prevalence of chronic diseases, rising demand for decentralized healthcare solutions, and technological advancements in diagnostic technologies.
POC diagnostics devices and equipment cover a broad spectrum of tests and applications, including blood glucose monitoring, infectious disease testing, cardiac markers analysis, pregnancy testing, and cholesterol screening, among others. These devices are typically compact, portable, and user-friendly, allowing for easy deployment in various healthcare settings such as hospitals, clinics, ambulatory care centers, and home care settings. POC diagnostics play a critical role in improving patient outcomes by facilitating early detection, monitoring disease progression, and guiding treatment decisions in real-time.
One of the key drivers of the Global POC Diagnostics Devices and Equipment Market is the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases. The growing burden of these conditions worldwide has created a pressing need for rapid and accessible diagnostic solutions that can be deployed at the point of care to enable early detection and management. POC diagnostics devices offer the advantage of timely diagnosis and monitoring, allowing for proactive interventions to prevent disease complications and improve patient outcomes.
Moreover, the shift towards decentralized healthcare delivery models and the rising demand for personalized medicine are driving the adoption of POC diagnostics devices and equipment. These devices empower healthcare providers to deliver diagnostic services closer to the patient, reducing turnaround times for test results and enhancing patient satisfaction. Additionally, advancements in technology, such as miniaturization, automation, and connectivity, have enabled the development of innovative POC diagnostics solutions that offer increased accuracy, reliability, and efficiency.
Despite the numerous drivers propelling market growth, the Global POC Diagnostics Devices and Equipment Market also faces certain challenges and constraints. These include regulatory hurdles, reimbursement limitations, and quality control issues associated with POC testing. Ensuring compliance with regulatory standards, securing reimbursement for POC tests, and maintaining quality assurance measures are critical factors that impact the adoption and utilization of POC diagnostics devices and equipment.
The Global POC Diagnostics Devices and Equipment Market presents significant opportunities for manufacturers, healthcare providers, and other stakeholders to address the evolving needs of the healthcare industry. By leveraging technological innovations, expanding market access, and addressing key challenges, the market has the potential to continue its growth trajectory and play a pivotal role in improving healthcare delivery and patient outcomes worldwide.
Global Point-Of-Care Diagnostics Devices And Equipment Market Recent Developments
- November 2022: UK-based LumiraDx Healthcare launched its highly sensitive C-Reactive Protein (CRP) point of care (POC) antigen test across India. The point of care CRP test can be used in multiple clinical settings to help reduce unnecessary antibiotic prescribing that leads to antimicrobial resistance (AMR).
- October 2022: Genes2Me Pvt. Ltd launched Rapi-Q- Point of Care RT PCR solution for human papillomavirus (HPV) and tuberculosis. The device is easy to use and gives faster results in less than 45 minutes. This CE-IVD-marked POC solution delivers superior performance, high sensitivity, and stable detection.
Segment Analysis
The Global Point-of-Care Diagnostics Devices and Equipment Market is segmented by type, prescription mode, and end user, each playing a key role in shaping the demand for these devices. The type segment includes a wide range of diagnostic devices, from blood glucose meters to diagnostic equipment for infectious diseases and pregnancy testing. As healthcare systems continue to shift towards more personalized, accessible, and efficient solutions, point-of-care diagnostics devices are becoming increasingly important. Devices that enable rapid results without the need for centralized labs are driving the market, as they reduce the time required for diagnosis and treatment initiation. This shift is particularly evident in managing chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases, where timely testing can greatly improve patient outcomes.
The prescription mode segment, which is divided into prescription-based testing devices and over-the-counter (OTC) testing devices, further reflects the varied demand across healthcare settings. Prescription-based testing devices are commonly used in clinical settings, such as hospitals and specialized medical centers, where professional interpretation of results is necessary. These devices often involve more complex testing, such as blood coagulation monitoring or advanced lipid profiling. Conversely, OTC testing devices are increasingly being used for personal health management, allowing consumers to monitor their health at home. OTC devices, such as glucose meters and pregnancy tests, are driving the consumer healthcare market by offering convenience, affordability, and ease of use, thus enabling individuals to take control of their health without the need for direct professional involvement.
The end user segment includes hospitals, clinics, home care settings, and diagnostic laboratories, each contributing to the growth of the point-of-care diagnostics devices market. Hospitals are significant end users due to the growing demand for quick, on-site diagnostic results, which enable faster decision-making in critical care, emergency departments, and surgical settings. Clinics, on the other hand, require reliable, easy-to-use devices for routine checks, particularly for monitoring chronic diseases like diabetes. The increasing shift toward home care has further boosted the demand for point-of-care diagnostics devices, as patients with chronic conditions are increasingly looking to monitor their health at home. Home care settings benefit from the growing availability of OTC devices, which allow for convenient testing and monitoring without requiring hospital visits. Additionally, diagnostic laboratories, especially those focusing on routine or preventive testing, are adopting point-of-care solutions to offer faster results and improve patient care.
Each of these segments plays a vital role in the overall expansion of the point-of-care diagnostics devices and equipment market. While prescription-based devices are critical for managing serious conditions that require professional oversight, OTC devices are democratizing healthcare by providing consumers with tools for self-monitoring and early detection. Hospitals, clinics, and home care settings each have unique needs and applications for point-of-care devices, driving continued innovation in the field. As demand for faster, more accurate diagnostics grows, the combination of these segments will help accelerate the adoption of point-of-care technologies across diverse healthcare environments.
Global Point-Of-Care Diagnostics Devices And Equipment Segment Analysis
In this report, the Global Point-Of-Care Diagnostics Devices And Equipment Market has been segmented by Type, Prescription Mode, End User and Geography.
Global Point-Of-Care Diagnostics Devices And Equipment Market, Segmentation by Type
The Global Point-Of-Care Diagnostics Devices And Equipment Market has been segmented by Type into Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits and Others.
Infectious disease testing kits represent a crucial segment within the POC diagnostics market, providing rapid detection and monitoring of infectious pathogens such as viruses and bacteria. These kits play a vital role in the early diagnosis and containment of infectious outbreaks, facilitating prompt treatment interventions and infection control measures. Cardio metabolic monitoring kits focus on assessing cardiovascular and metabolic health parameters, including blood glucose levels, lipid profiles, and cardiac markers. These kits aid in the management of chronic conditions such as diabetes and cardiovascular diseases, enabling timely interventions to prevent complications.
Cholesterol testing kits are essential tools for assessing lipid levels in the blood, aiding in the identification of individuals at risk of cardiovascular events such as heart attacks and strokes. Pregnancy and fertility tests kits enable convenient and reliable detection of pregnancy hormones and fertility indicators, supporting family planning and reproductive health management. Tumor/cancer markers kits are utilized for the detection of specific biomarkers associated with various types of cancer, facilitating early diagnosis, treatment planning, and monitoring of cancer progression.
Urinalysis testing kits provide rapid analysis of urine samples to assess kidney function, urinary tract infections, and metabolic disorders. Hematology testing kits offer on-the-spot analysis of blood samples, including complete blood counts and hemoglobin levels, aiding in the diagnosis and monitoring of hematological conditions. Drugs of abuse testing kits enable rapid screening for the presence of illicit substances in biological samples, supporting drug rehabilitation programs and workplace drug testing initiatives.
Fecal occult testing kits are utilized for the detection of occult blood in stool samples, aiding in the early detection of gastrointestinal bleeding and colorectal cancer. The "Others" category encompasses a diverse range of POC diagnostic devices catering to additional healthcare needs, such as allergy testing, autoimmune disease screening, and coagulation monitoring. Collectively, these segments reflect the versatility and breadth of the POC diagnostics market, providing essential tools for timely diagnosis, monitoring, and management of various health conditions at the point of care.
Global Point-Of-Care Diagnostics Devices And Equipment Market, Segmentation by Prescription Mode
The Global Point-Of-Care Diagnostics Devices And Equipment Market has been segmented by Prescription Mode into Prescription-based Testing Devices, and Over-The-Counter (OTC) Testing Devices.
Prescription-based testing devices are those that require a healthcare professional’s approval or prescription for use. These devices are typically used in clinical settings, hospitals, and specialized medical centers, where they assist in diagnosing and monitoring various health conditions. They often include devices for more complex or critical tests, such as blood glucose monitoring for diabetes management, cholesterol testing, and coagulation tests, which require professional interpretation and guidance. The demand for prescription-based devices continues to grow as healthcare providers seek to manage chronic diseases, monitor acute conditions, and offer personalized treatment through real-time testing.
On the other hand, over-the-counter (OTC) testing devices are designed for use by individuals without a prescription, making them more accessible for home healthcare or personal use. These devices typically focus on non-invasive and simpler tests that can be easily performed by consumers, such as pregnancy tests, ovulation monitoring kits, blood glucose meters, and cholesterol testing devices. OTC testing devices have seen significant growth due to the increasing trend toward self-management of health conditions, especially among consumers with chronic illnesses such as diabetes and hypertension. The convenience of using these devices at home without the need for a healthcare professional has contributed to their widespread adoption.
The prescription-based testing devices segment is often more advanced and may involve more complex technology or processes, offering healthcare professionals comprehensive diagnostic information. These devices require careful handling, calibration, and interpretation of results, which are critical in clinical settings to ensure patient safety and effective treatment. The OTC segment, on the other hand, empowers individuals to take charge of their health by offering accessible, easy-to-use devices that provide immediate results. This growing demand for consumer-driven health management solutions is reshaping the point-of-care diagnostics landscape, with more people opting to monitor and manage their health at home.
Both prescription-based and OTC testing devices play crucial roles in expanding the point-of-care diagnostics market. The increasing focus on preventive healthcare, early detection, and patient empowerment is driving growth in both segments. Prescription-based devices are essential in managing more serious or complex conditions, while OTC devices support individuals in their daily health monitoring and chronic disease management. The combination of both types of devices allows for a more comprehensive approach to healthcare, contributing to the overall advancement of point-of-care diagnostics.
Global Point-Of-Care Diagnostics Devices And Equipment Market, Segmentation by End User
The Global Point-Of-Care Diagnostics Devices And Equipment Market has been segmented by End User into Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories and Home.
The Global Point-of-Care Diagnostics Devices and Equipment Market is segmented by end user into various categories, reflecting the diverse settings where these diagnostic tools are utilized. These segments include professional diagnostic centers, hospitals/critical care centers, outpatient healthcare settings, ambulatory care settings, research laboratories, and home environments. Each segment represents a distinct healthcare setting where point-of-care diagnostics play a crucial role in facilitating rapid and accurate diagnosis, enabling timely interventions and treatment decisions.
Professional diagnostic centers serve as specialized facilities equipped with advanced diagnostic equipment and trained healthcare professionals to conduct a wide range of diagnostic tests. These centers cater to patients referred by primary care physicians or specialists for specialized testing and evaluation, ensuring comprehensive diagnostic services in a clinical setting.
Hospitals and critical care centers represent another significant segment of the market, where point-of-care diagnostics devices are integrated into the clinical workflow to support emergency care, intensive care, and surgical interventions. These settings require rapid diagnostic capabilities to facilitate prompt decision-making and patient management in critical situations, such as emergency department admissions, operating rooms, and intensive care units.
Outpatient healthcare settings, including clinics and medical offices, provide diagnostic services to patients requiring routine or non-emergency care. Point-of-care diagnostics devices are utilized in these settings to support primary care providers in diagnosing and managing various health conditions, enabling efficient patient triage, treatment planning, and follow-up care.
Ambulatory care settings encompass a wide range of healthcare facilities, such as urgent care centers, community health centers, and specialty clinics, where patients receive same-day medical services without the need for hospitalization. Point-of-care diagnostics devices are essential in these settings to facilitate rapid diagnosis and treatment decisions, enhancing the efficiency and effectiveness of ambulatory care delivery.
Research laboratories represent a segment of the market where point-of-care diagnostics devices are utilized for research purposes, including clinical trials, epidemiological studies, and biomarker discovery. These devices enable researchers to conduct rapid diagnostic testing and gather real-time data to support scientific research and innovation in healthcare.
The home environment represents an emerging segment of the market, where individuals have access to point-of-care diagnostics devices for self-testing and monitoring of various health parameters. Home-based diagnostics devices enable individuals to take a proactive approach to their health, monitor chronic conditions, and facilitate early detection of health issues, empowering patients to manage their health and well-being from the comfort of their homes.
Global Point-Of-Care Diagnostics Devices And Equipment Market, Segmentation by Geography
In this report, the Global Point-Of-Care Diagnostics Devices And Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Point-Of-Care Diagnostics Devices And Equipment Market Share (%), by Geographical Region, 2024
The distribution of market share in the Global Point-of-Care (POC) Diagnostics Devices and Equipment Market varies significantly across different geographical regions, reflecting diverse healthcare infrastructures, regulatory frameworks, and disease burdens. Understanding this breakdown provides valuable insights into regional healthcare needs, market dynamics, and opportunities for growth within the POC diagnostics industry. Each geographic region contributes differently to the overall market share, influenced by factors such as healthcare expenditure, accessibility of healthcare services, and adoption rates of POC diagnostic technologies.
North America typically commands a substantial portion of the global POC diagnostics devices and equipment market share, with the United States being a primary driver of this dominance. The region benefits from a well-established healthcare system, high healthcare expenditure, and a strong emphasis on technological innovation. North American healthcare providers prioritize investments in POC diagnostics devices and equipment to improve patient outcomes, enhance healthcare delivery, and reduce costs associated with traditional laboratory testing.
Europe follows closely behind North America in terms of market share, with countries such as the United Kingdom, Germany, and France playing significant roles in shaping the adoption of POC diagnostic technologies. The European market is characterized by universal healthcare coverage, stringent regulatory standards, and a growing demand for decentralized healthcare solutions. European healthcare systems are increasingly adopting POC diagnostics devices and equipment to streamline patient care, reduce diagnostic turnaround times, and optimize resource allocation in healthcare settings.
Asia-Pacific represents a rapidly growing market for POC diagnostics devices and equipment, driven by countries such as China, Japan, and India. The region's market share is propelled by factors such as increasing healthcare expenditure, rising prevalence of chronic diseases, and expanding access to healthcare services. Asian healthcare providers recognize the value of POC diagnostics in improving healthcare access, especially in rural and remote areas where traditional laboratory facilities may be limited. Additionally, government initiatives aimed at strengthening healthcare infrastructure and promoting early disease detection further contribute to market growth in the region.
Latin America and the Middle East & Africa (MEA) regions also contribute to the global POC diagnostics devices and equipment market share, albeit to a lesser extent compared to other regions. These regions are characterized by diverse healthcare landscapes, varying levels of healthcare infrastructure, and significant unmet healthcare needs. POC diagnostics devices and equipment offer opportunities to address challenges such as limited access to healthcare facilities, long wait times for diagnostic testing, and high disease burdens. By leveraging POC diagnostics technologies, healthcare providers in Latin America and MEA can improve diagnostic capabilities, enhance patient outcomes, and strengthen healthcare delivery systems.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Point-Of-Care Diagnostics Devices And Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising Prevalence of Chronic Diseases
- Shift Towards Decentralized Healthcare
-
Technological Advancements: Technological advancements have played a pivotal role in transforming point-of-care (POC) diagnostics devices and equipment. Miniaturization, automation, and connectivity have collectively revolutionized the capabilities of these devices, making them more efficient, accurate, and user-friendly. These innovations have led to the development of compact and portable POC diagnostic solutions that offer improved performance and ease of use, driving their adoption rates across various healthcare settings.
Miniaturization has enabled the design of smaller and more portable POC diagnostic devices, allowing for easier deployment and use in diverse healthcare environments. Automation features have streamlined testing processes, reducing manual errors and increasing the efficiency of diagnostic procedures. Moreover, the integration of connectivity technologies such as wireless communication and cloud-based data management has facilitated real-time data sharing, remote monitoring, and seamless integration with electronic health records, enhancing the utility and effectiveness of POC diagnostics devices.
These technological advancements have not only improved the accuracy and reliability of POC diagnostics but have also enhanced their accessibility and usability. By offering more efficient and user-friendly solutions, advancements in technology have driven the adoption rates of POC diagnostics devices and equipment, contributing to the overall growth and evolution of the market.
Restraints
- Regulatory Hurdles and Compliance Challenges
- Reimbursement Limitations
-
Quality Control and Assurance: Ensuring the accuracy, reliability, and safety of point-of-care (POC) diagnostic tests is paramount to their effectiveness in healthcare settings. Quality control and assurance measures are vital components in achieving this objective. Variability in test results, inaccuracies in instrument calibration, and inconsistencies in user proficiency can all compromise the performance and credibility of POC diagnostics devices. Therefore, implementing robust quality management systems is crucial to mitigate these risks and uphold the integrity of diagnostic testing.
To address quality control challenges, healthcare providers and manufacturers must prioritize the establishment of stringent quality assurance protocols. This includes regular calibration and maintenance of diagnostic instruments to ensure consistent and accurate results. Additionally, comprehensive training programs should be implemented to educate healthcare professionals on the proper use and handling of POC devices. By enhancing user proficiency and adherence to best practices, organizations can minimize errors and improve the overall reliability of diagnostic testing.
Maintaining market credibility in the POC diagnostics sector hinges on the implementation of effective quality management strategies. By proactively addressing quality control issues and investing in continuous training and improvement initiatives, stakeholders can instill confidence in the accuracy and reliability of POC diagnostic tests. Ultimately, stringent quality assurance measures are essential not only for safeguarding patient safety but also for sustaining the trust and credibility of POC diagnostics devices within the healthcare industry.
Opportunities
- Expansion in Emerging Markets
- Integration with Telehealth and Remote Monitoring
-
Focus on Personalized Medicine: The increasing emphasis on personalized medicine and precision healthcare offers significant opportunities for the growth of POC diagnostics devices and equipment. Personalized medicine endeavors to customize medical treatments and interventions based on individual patient attributes, such as genetic variations, lifestyle choices, and susceptibility to specific diseases. In this context, POC diagnostics devices play a pivotal role by providing rapid and tailored diagnostic insights that aid healthcare professionals in making informed treatment decisions aligned with each patient's unique characteristics and needs. As personalized medicine continues to gain traction, there is a rising demand for advanced POC testing technologies capable of delivering accurate and targeted diagnostic information, thereby fueling market expansion and innovation in the field.
POC diagnostics devices are instrumental in delivering timely and precise diagnostic information, which is essential for supporting personalized treatment approaches. By enabling healthcare providers to assess individual patient characteristics, including genetic markers, biomarkers, and disease risk profiles, POC diagnostics devices empower clinicians to tailor interventions and therapies accordingly. This capability not only enhances patient care outcomes but also contributes to the optimization of healthcare resources and the reduction of treatment-related complications. Consequently, the growing adoption of personalized medicine principles drives the demand for advanced POC diagnostics technologies, fostering market growth and diversification.
As the healthcare industry continues to evolve towards a more patient-centric and data-driven approach, the role of POC diagnostics devices in supporting personalized medicine strategies becomes increasingly vital. These devices facilitate the delivery of precise and actionable diagnostic insights at the point of care, enabling healthcare providers to deliver targeted and effective interventions tailored to each patient's unique characteristics and needs. Moreover, the integration of advanced testing technologies and analytics capabilities in POC diagnostics devices further enhances their utility in personalized medicine applications, driving continued innovation and market expansion in the dynamic healthcare landscape.
Competitive Landscape Analysis
Key players in Global Point-Of-Care Diagnostics Devices And Equipment Market include.
- Abbott
- F. Hoffmann-La Roche
- Siemens Healthineers
- Danaher
- Beckman Coulter
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Prescription Mode
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Point-Of-Care Diagnostics Devices And Equipment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising Prevalence of Chronic Diseases
- Shift Towards Decentralized Healthcare
- Technological Advancements
- Restraints
- Regulatory Hurdles and Compliance Challenges
- Reimbursement Limitations
- Quality Control and Assurance
- Opportunities
- Expansion in Emerging Markets
- Integration with Telehealth and Remote Monitoring
- Focus on Personalized Medicine
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Point-Of-Care Diagnostics Devices And Equipment Market, By Type, 2021 - 2031 (USD Million)
- Infectious disease testing kits
- Cardio metabolic monitoring kits,
- Cholesterol testing kits
- Pregnancy and fertility tests kits
- Tumor/cancer markers
- Urinalysis testing kits
- Hematology testing kits
- Drugs of abuse testing kits
- Fecal occult testing kits
- Others
- Global Point-Of-Care Diagnostics Devices And Equipment Market, By Prescription Mode, 2021 - 2031 (USD Million)
- Prescription-based Testing Devices
- Over-The-Counter (OTC) Testing Devices
- Global Point-Of-Care Diagnostics Devices And Equipment Market, By End User, 2021 - 2031 (USD Million)
- Professional diagnostic centers
- Hospitals/critical care centers
- Outpatient healthcare Setting
- Ambulatory care settings
- Research laboratories
- Home
- Global Point-Of-Care Diagnostics Devices And Equipment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Point-Of-Care Diagnostics Devices And Equipment Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Abbott
- F. Hoffmann-La Roche
- Siemens Healthineers
- Danaher
- Beckman Coulter
- Company Profiles
- Analyst Views
- Future Outlook of the Market